Colgate-Palmolive (NYSE:CL) Given Consensus Recommendation of “Hold” by Analysts

Colgate-Palmolive (NYSE:CLGet Rating) has been assigned an average rating of “Hold” from the twenty-one ratings firms that are covering the company, reports. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $84.93.

CL has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft lowered their price target on Colgate-Palmolive from $91.00 to $88.00 in a report on Monday, May 2nd. Credit Suisse Group lowered their price target on Colgate-Palmolive from $95.00 to $90.00 and set an “outperform” rating on the stock in a report on Monday, January 31st. Citigroup upped their price target on Colgate-Palmolive from $83.00 to $86.00 and gave the company a “neutral” rating in a report on Monday, January 31st. Morgan Stanley upped their price objective on Colgate-Palmolive from $90.00 to $91.00 and gave the company an “equal weight” rating in a research report on Monday, January 31st. Finally, Barclays reduced their price objective on Colgate-Palmolive from $81.00 to $77.00 in a research report on Tuesday, May 3rd.

In other Colgate-Palmolive news, Director John P. Bilbrey sold 4,917 shares of the business’s stock in a transaction on Monday, February 14th. The shares were sold at an average price of $78.66, for a total value of $386,771.22. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.32% of the company’s stock.

Institutional investors have recently bought and sold shares of the company. Core Alternative Capital grew its holdings in Colgate-Palmolive by 924.3% during the 1st quarter. Core Alternative Capital now owns 379 shares of the company’s stock valued at $29,000 after purchasing an additional 342 shares during the last quarter. Verity Asset Management Inc. bought a new position in Colgate-Palmolive in the 1st quarter worth about $29,000. Horan Securities Inc. purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $30,000. Carl Stuart Investment Advisor Inc. purchased a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $30,000. Finally, Fortis Advisors LLC purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $38,000. Hedge funds and other institutional investors own 78.12% of the company’s stock.

Colgate-Palmolive stock opened at $77.55 on Friday. The company has a current ratio of 1.09, a quick ratio of 0.67 and a debt-to-equity ratio of 10.42. The business’s fifty day simple moving average is $77.25 and its two-hundred day simple moving average is $79.11. Colgate-Palmolive has a 12 month low of $72.20 and a 12 month high of $85.61. The company has a market capitalization of $64.98 billion, a price-to-earnings ratio of 32.05, a price-to-earnings-growth ratio of 5.13 and a beta of 0.56.

Colgate-Palmolive (NYSE:CLGet Rating) last announced its quarterly earnings results on Friday, April 29th. The company reported $0.74 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.74. The firm had revenue of $4.40 billion for the quarter, compared to the consensus estimate of $4.40 billion. Colgate-Palmolive had a return on equity of 296.77% and a net margin of 11.70%. The company’s quarterly revenue was up 1.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.80 earnings per share. On average, equities research analysts predict that Colgate-Palmolive will post 3.08 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 13th. Shareholders of record on Thursday, April 21st will be issued a dividend of $0.47 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.45. This represents a $1.88 dividend on an annualized basis and a yield of 2.42%. The ex-dividend date is Wednesday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 77.69%.

Colgate-Palmolive declared that its Board of Directors has authorized a share buyback program on Thursday, March 10th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to buy up to 8.1% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

About Colgate-Palmolive (Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.